CDI-DAYSYMS

Welcome to the Brand page for “CDI-DAYSYMS”, which is offered here for Design and development of software for generating and analyzing patient-reported data in clostridium difficile associated infections;.

Its status is currently believed to be active. Its class is unavailable. “CDI-DAYSYMS” is believed to be currently owned by “Actelion Pharmaceuticals Ltd”.


Owner:
ACTELION PHARMACEUTICALS LTD
Owner Details
Description:
Design and development of software for generating and analyzing patient-reported data in Clostridium Difficile Associated Infections;
Categories: DESIGN DEVELOPMENT SOFTWARE